Regeneron Pharmaceuticals Inc 2022 SR
The report highlights Regeneron's progress in 2022 across its three responsibility pillars: improving lives, fostering integrity, and building sustainable communities. The company reinvested $3.6 billion in R&D and advanced a pipeline of approximately 35 investigational medicines. Regeneron achieved a 14% reduction in Scope 1 and 2 emissions intensity compared to its 2016 baseline and maintained 100% waste diversion from landfills at all owned sites. The workforce grew by 14%, with women making up 33% of leadership positions. Additionally, the company provided STEM experiences to 1.7 million students since 2020, progressing toward its 2025 goal.
Company: Regeneron Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2022
Type: SR
Pages: 82
Back to company
Regeneron Pharmaceuticals Inc
Responsibility Report
The report highlights Regeneron's progress in 2022 across its three responsibility pillars: improving lives, fostering integrity, and building sustainable communities. The company reinvested $3.6 billion in R&D and advanced a pipeline of approximately 35 investigational medicines. Regeneron achieved a 14% reduction in Scope 1 and 2 emissions intensity compared to its 2016 baseline and maintained 100% waste diversion from landfills at all owned sites. The workforce grew by 14%, with women making up 33% of leadership positions. Additionally, the company provided STEM experiences to 1.7 million students since 2020, progressing toward its 2025 goal.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees